Managers / Q4 2024 · view latest →
Michelson Medical Research Foundation, Inc.
CIK 0001965304 · 11755 WILSHIRE BLVD., SUITE 1400, LOS ANGELES, CA, 90025 · (310) 806-9700
Summary
Michelson Medical Research Foundation, Inc. reported $119M in U.S.-listed holdings across 28 positions for Q4 2024.
The portfolio is heavily concentrated: IVE alone accounts for 24.4% of reported value.
Compared with Q3 2024, the fund opened 1 new position and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 58.0% · $69M
- Common Stock · 28.0% · $33M
- REIT · 9.3% · $11M
- ADR · 3.8% · $5M
- Closed-End Fund · 0.9% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ELLAUDER ESTEE COS INC | NEW | +80.0K | 80.0K | +$6M | $6M |
| EPAMEPAM SYS INC | SOLD OUT | −10.0K | 0 | −$2M | $0 |
| AVBAVALONBAY CMNTYS INC | TRIMMED | −14.4K | 1.9K | −$3M | $428,282 |
| MTNVAIL RESORTS INC | ADDED | +36.0K | 86.0K | +$7M | $16M |
| SUISUN CMNTYS INC | TRIMMED | −30.0K | 20.0K | −$4M | $2M |
| VEAVANGUARD TAX-MANAGED FDS | TRIMMED | −203.0K | 158.2K | −$12M | $8M |
| VWOVANGUARD INTL EQUITY INDEX F | TRIMMED | −109.0K | 127.6K | −$6M | $6M |
| VBVANGUARD INDEX FDS | TRIMMED | −7.9K | 11.0K | −$2M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IVEISHARES TR | S&P 500 VAL ETF · CORE S&P500 ETF · ISHARES BIOTECH · MICRO-CAP ETF | 24.37% | $29M | 145.7K |
| 2 | MTNVAIL RESORTS INChistory → | COM | 13.51% | $16M | 86.0K |
| 3 | GDXVANECK ETF TRUSThistory → | GOLD MINERS ETF | 6.66% | $8M | 234.3K |
| 4 | EWWISHARES INC | MSCI MEXICO ETF · MSCI BRAZIL ETF · MSCI TAIWAN ETF · MSCI JPN ETF NEW · MSCI STH KOR ETF | 6.36% | $8M | 190.8K |
| 5 | VEAVANGUARD TAX-MANAGED FDShistory → | VAN FTSE DEV MKT | 6.34% | $8M | 158.2K |
| 6 | KRESPDR SER TR | S&P REGL BKG · S&P BIOTECH | 6.26% | $7M | 108.4K |
| 7 | CMPCOMPASS MINERALS INTL INChistory → | COM | 5.66% | $7M | 600.0K |
| 8 | ELLAUDER ESTEE COS INChistory → | CL A | 5.03% | $6M | 80.0K |
| 9 | VWOVANGUARD INTL EQUITY INDEX Fhistory → | FTSE EMR MKT ETF | 4.71% | $6M | 127.6K |
| 10 | RTORENTOKIL INITIAL PLChistory → | SPONSORED ADR | 3.82% | $5M | 180.0K |
| 11 | AREALEXANDRIA REAL ESTATE EQ INhistory → | COM | 3.04% | $4M | 37.2K |
| 12 | PLDPROLOGIS INC.history → | COM | 2.49% | $3M | 28.1K |
| 13 | VBVANGUARD INDEX FDShistory → | SMALL CP ETF | 2.22% | $3M | 11.0K |
| 14 | SUISUN CMNTYS INChistory → | COM | 2.06% | $2M | 20.0K |
| 15 | BURBURFORD CAP LTDhistory → | ORD SHS | 1.92% | $2M | 180.0K |
| 16 | CRGYCRESCENT ENERGY COMPANYhistory → | CL A COM | 1.91% | $2M | 156.2K |
| 17 | BXPBXP INChistory → | COM | 1.35% | $2M | 21.7K |
| 18 | GXCSPDR INDEX SHS FDShistory → | S&P CHINA ETF | 1.07% | $1M | 16.8K |
| 19 | NMLNEUBERGER BERMAN ENERGY INFR | COM | 0.86% | $1M | 115.9K |
| 20 | AVBAVALONBAY CMNTYS INC | COM | 0.36% | $428,282 | 1.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $99M | 21 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $100M | 20 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $115M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 20 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $120M | 25 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $119M | 28 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $142M | 28 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $116M | 25 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $165M | 28 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $152M | 28 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $148M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $141M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $128M | 21 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $154M | 31 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.